These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 22078851

  • 1. Efficacy and safety of garenoxacin in the treatment of upper respiratory tract infections.
    Ito M, Maruyama Y, Murono S, Wakisaka N, Kondo S, Hatano M, Nakanishi S, Miwa T, Yoshizaki T.
    Auris Nasus Larynx; 2012 Oct; 39(5):512-8. PubMed ID: 22078851
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections.
    Van Wart S, Phillips L, Ludwig EA, Russo R, Gajjar DA, Bello A, Ambrose PG, Costanzo C, Grasela TH, Echols R, Grasela DM.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4766-77. PubMed ID: 15561855
    [Abstract] [Full Text] [Related]

  • 3. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]

  • 4. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
    Jones RN, Fritsche TR, Sader HS, Stilwell MG.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
    [Abstract] [Full Text] [Related]

  • 5. Clinical studies of garenoxacin.
    Takagi H, Tanaka K, Tsuda H, Kobayashi H.
    Int J Antimicrob Agents; 2008 Dec; 32(6):468-74. PubMed ID: 18790608
    [Abstract] [Full Text] [Related]

  • 6. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN, Sader HS, Stilwell MG, Fritsche TR.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [Abstract] [Full Text] [Related]

  • 7. Bacterial infections of the upper respiratory airways and beta-lactam antibiotics.
    Lundberg C.
    Scand J Infect Dis Suppl; 1984 May; 42():122-8. PubMed ID: 6597557
    [Abstract] [Full Text] [Related]

  • 8. Guidelines to rational use of antibiotics in acute upper respiratory tract infections in Chinese children.
    Yang Y, Lu Q, Chen H.
    Chin Med J (Engl); 2001 Apr; 114(4):339-43. PubMed ID: 11780449
    [No Abstract] [Full Text] [Related]

  • 9. Use of antimicrobial agents for upper respiratory tract infections in Taiwanese children.
    Huang YH, Huang YC.
    Chang Gung Med J; 2005 Nov; 28(11):758-64. PubMed ID: 16422181
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC, Gillespie SH, Burley CJ, Tillotson GS.
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [Abstract] [Full Text] [Related]

  • 11. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods.
    Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, Sande MA.
    Ann Emerg Med; 2001 Jun; 37(6):690-7. PubMed ID: 11385342
    [Abstract] [Full Text] [Related]

  • 12. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B.
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [Abstract] [Full Text] [Related]

  • 13. [Rational antibiotic therapy of acute upper respiratory tract infections].
    Mazur E.
    Pol Merkur Lekarski; 2010 Nov; 29(173):304-8. PubMed ID: 21268914
    [Abstract] [Full Text] [Related]

  • 14. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections.
    Blondeau JM, Tillotson G.
    Int J Antimicrob Agents; 2008 Apr; 31(4):299-306. PubMed ID: 18276120
    [Abstract] [Full Text] [Related]

  • 15. An approach to pediatric upper respiratory infections.
    Middleton DB.
    Am Fam Physician; 1991 Nov; 44(5 Suppl):33S-40S, 46S-47S. PubMed ID: 1950981
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: postmarketing surveillance in Japan.
    Izumikawa K, Watanabe A, Miyashita N, Ishida T, Hosono H, Kushimoto S, Kohno S.
    J Infect Chemother; 2014 Sep; 20(9):541-8. PubMed ID: 24934886
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of upper respiratory tract infections (acute tonsillopharyngitis, acute rhinosinusitis, acute otitis media)].
    Ludwig E.
    Orv Hetil; 2003 Sep 21; 144(38):1881-2. PubMed ID: 14596027
    [No Abstract] [Full Text] [Related]

  • 19. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S, Ianniello F, Leone S, Esposito S.
    J Antimicrob Chemother; 2003 Nov 21; 52(5):869-72. PubMed ID: 14519672
    [Abstract] [Full Text] [Related]

  • 20. Clinical experience with moxifloxacin in patients with respiratory tract infections.
    Faich GA, Morganroth J, Whitehouse AB, Brar JS, Arcuri P, Kowalsky SF, Haverstock DC, Celesk RA, Church DA.
    Ann Pharmacother; 2004 May 21; 38(5):749-54. PubMed ID: 15026565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.